In the next phase of our investigation, we evaluated the P-gp-inhibitory activities of TKIs in P-gp-overexpressing KBV20C cells as TKIs have been suggested to sensitize resistant cancer cells with strong P-gp inhibitory activity (27, 28). Here, PGP is linked to cancer.